Cancer Statistics, CA Cancer J Clin, vol.67, pp.7-30, 2017. ,
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, issue.6, pp.24-32, 2013. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 2011. ,
Decoding and unlocking the BCL-2 dependency of cancer cells, Nat Rev Cancer, vol.13, pp.455-65, 2013. ,
First evidence that oligopyridines, ?-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies, J Med Chem, vol.58, pp.1644-68, 2015. ,
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis, Apoptosis, vol.18, pp.492-508, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00872602
Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis, Int J Cancer, vol.126, pp.885-95, 2010. ,
Targeting mTOR pathway in gynecological malignancies: biological rationale and systematic review of published data, Crit Rev Oncol Hematol, vol.108, pp.1-12, 2016. ,
The PI3K/ AKT/mTOR pathway as a therapeutic target in ovarian cancer, Sci Transl Med, vol.137, pp.369-175, 2015. ,
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition, Proc Natl Acad Sci USA, vol.106, pp.19503-19511, 2009. ,
PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced, Cancer Lett, vol.348, pp.38-49, 2014. ,
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response, Nat Commun, vol.8, p.365, 2017. ,
The versatility and universality of calcium signalling, Nat Rev Mol Cell Biol, vol.1, pp.11-21, 2000. ,
Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?, Philos Trans R Soc Lond B Biol Sci, vol.369, 2014. ,
Targeting calcium signaling in cancer therapy, Acta Pharm Sin B, vol.7, pp.3-17, 2017. ,
The calcium-cancer signalling nexus, Nat Rev Cancer, vol.17, pp.367-80, 2017. ,
Calcium channels and pumps in cancer: changes and consequences, J Biol Chem, vol.287, pp.31666-73, 2012. ,
Targeting Ca² + transport in cancer: close reality or long perspective?, Expert Opin Ther Targets, vol.17, pp.225-266, 2013. ,
Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70S6k, J Biol Chem, vol.273, pp.4776-82, 1998. ,
Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex, Biochem J, vol.370, pp.469-77, 2003. ,
An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells, J Biol Chem, vol.272, pp.1920-1948, 1997. ,
Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34, Cell Metab, vol.7, pp.456-65, 2008. ,
Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling, Mol Cell Biol, vol.33, pp.293-306, 2013. ,
Intracellular calcium and calmodulin link brain-derived neurotrophic factor to p70S6 kinase phosphorylation and dendritic protein synthesis, J Neurosci Res, vol.88, pp.1420-1452, 2010. ,
hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway, Cytokine, vol.62, pp.310-331, 2013. ,
Regulation of mTORC1 by lysosomal calcium and calmodulin, eLife, vol.5, p.5, 2016. ,
Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach, J Cell Physiol, vol.197, pp.370-78, 2003. ,
Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells, Biochem Biophys Res Commun, vol.301, pp.907-921, 2003. ,
Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole, FASEB J, vol.16, pp.1805-1812, 2002. ,
Arachidonic acid-induced Ca2+ entry is involved in early steps of tumor angiogenesis, Mol Cancer Res, vol.6, pp.535-580, 2008. ,
CAI inhibits the growth of small cell lung cancer cells, Lung Cancer, vol.39, pp.279-88, 2003. ,
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole, Clin Cancer Res, vol.3, pp.1915-1936, 1997. ,
The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells, Cell Calcium, vol.36, pp.459-67, 2004. ,
Storeoperated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients, PLoS One, vol.7, p.42541, 2012. ,
Carboxyamidotriazole-induced www.oncotarget.com inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells, J Cell Sci, vol.118, pp.5615-5638, 2005. ,
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors, Cancer Biol Ther, vol.8, pp.1800-1805, 2009. ,
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer, Clin Cancer Res, vol.5, pp.2324-2353, 1999. ,
Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food, Clin Cancer Res, vol.8, pp.86-94, 2002. ,
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study, Cancer, vol.104, pp.2392-99, 2005. ,
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer, J Clin Oncol, vol.21, pp.4356-63, 2003. ,
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers, Cancer Res, vol.56, pp.569-73, 1996. ,
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction, Clin Cancer Res, vol.7, pp.1600-1609, 2001. ,
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas, J Clin Oncol, vol.36, pp.1702-1711, 2018. ,
Mcl-1; the molecular regulation of protein function, FEBS Lett, vol.584, pp.2981-89, 2010. ,
Methods for studying store-operated calcium entry, Methods, vol.46, pp.204-216, 2008. ,
STIM and calcium channel complexes in cancer, Biochim Biophys Acta, vol.1863, pp.1418-1444, 2016. ,
Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps, J Biol Chem, vol.266, pp.17067-71, 1991. ,
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition, Mol Cancer Ther, vol.8, pp.742-53, 2009. ,
mTOR signaling in growth control and disease, Cell, vol.149, pp.274-93, 2012. ,
SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKII?/AKT-mediated pathway, Cancer Lett, vol.372, pp.226-264, 2016. ,
The emerging role of CaMKII in cancer, Oncotarget, vol.6, pp.11725-11734, 2015. ,
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism, Nat Cell Biol, vol.13, pp.1016-1039, 2011. ,
A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes, J Immunol, vol.170, pp.4441-4490, 2003. ,
Mcl-1 downregulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation, Cancer Res, vol.67, pp.782-91, 2007. ,
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737, Clin Cancer Res, vol.18, pp.783-95, 2012. ,
Effects of carboxyamidotriazole on in vitro models of imatinibresistant chronic myeloid leukemia, J Cell Physiol, vol.215, pp.111-132, 2008. ,
Antiproliferative and antiinvasive effects of carboxyamidotriazole on breast cancer cell lines, Surgery, vol.122, pp.372-78, 1997. ,
Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis, J Pharmacol Exp Ther, vol.362, pp.219-248, 2017. ,
Carboxyamidotriazole inhibits proliferation of human breast cancer cells www.oncotarget.com via G(2)/M cell cycle arrest and apoptosis, Eur J Pharmacol, vol.538, pp.15-22, 2006. ,
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency, Int J Cancer, vol.123, pp.258-63, 2008. ,
Carboxyamidotriazole induces apoptosis in bovine aortic endothelial and human glioma cells, Clin Cancer Res, vol.6, pp.1248-54, 2000. ,
Thapsigargin-induced gene expression in nonexcitable cells is dependent on calcium influx, Mol Endocrinol, vol.11, pp.281-91, 1997. ,
Akt activation by Ca2+/ calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells, J Biol Chem, vol.292, pp.14188-204, 2017. ,
AMP-activated protein kinase: a universal regulator of autophagy?, Autophagy, vol.3, pp.381-83, 2007. ,
Store-operated calcium entry-activated autophagy protects EPC proliferation via the CAMKK2-MTOR pathway in ox-LDL exposure, Autophagy, vol.13, pp.82-98, 2017. ,
ORAI1 deficiency impairs activated T cell death and enhances T cell survival, J Immunol, vol.187, pp.3620-3650, 2011. ,
Location and function of STIM1 in the activation of Ca2+ entry signals, J Biol Chem, vol.283, pp.26252-62, 2008. ,
Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover, Cancer Lett, vol.330, pp.163-69, 2013. ,
Inhibition of Orai1-mediated Ca 2+ entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5-fluorouracil, J Cell Mol Med, vol.21, pp.904-919, 2017. ,
STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion, Pflugers Arch, vol.465, pp.1249-60, 2013. ,
Orai1 and STIM1 are critical for breast tumor cell migration and metastasis, Cancer Cell, vol.15, pp.124-158, 2009. ,
Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis, Proc Natl Acad Sci USA, vol.108, pp.15225-15255, 2011. ,
Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells, Oncotarget, vol.5, pp.4799-810, 2014. ,
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis, Cancer Res, vol.65, pp.3853-60, 2005. ,
Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anticancer effect with glycolysis inhibition, Cancer Lett, vol.370, pp.232-273, 2016. ,
Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors, Cell Death Dis, vol.7, p.2466, 2016. ,